Anixa Biosciences ANIX
NASDAQ ANIX
$2.99 +0.21 (+7.55%)
At close: Oct 23, 2026 · 4:00 PM EDT

Anixa Biosciences (ANIX) Amortization of Deferred Charges (2013 - 2014)

Updated

Analysis

Anixa Biosciences (ANIX) Amortization of Deferred Charges (2013 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Anixa Biosciences 101.52 Mn 87.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2014 59,057.00
Jul 31, 2014 128,645.00
Apr 30, 2014 229,249.00
Jan 31, 2014 217,316.00
Oct 31, 2013 98,031.00
Jul 31, 2013 229,964.00
Apr 30, 2013 795,891.00
Jan 31, 2013 5,234.00
API Access

Anixa Biosciences Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ANIX&period=max&api_key=YOUR_API_KEY